Recce Pharmaceuticals Extends Share Purchase Plan Closing Date
MT Newswires Live
Jul 20
Recce Pharmaceuticals (ASX:RCE) has extended the closing date of its share purchase plan (SPP) to Friday, providing eligible shareholders with additional time to subscribe for shares under the offer, according to a Monday Australian bourse filing.
The SPP allows shareholders to acquire up to AU$30,000 worth of fully paid ordinary shares at AU$0.40 per share, with no brokerage or transaction fees applicable, the filing said.
Participants will also have the opportunity to apply for free attaching options, subject to shareholder approval, which may include additional "piggyback" options upon exercise, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.